<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "cetuximab inj VIAL">
<dose><value>400</value>
<value>250</value>
<value>200</value>
<value>150</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>cetuximab inj VIAL</value>
</drugname><strength><value>2 mg/mL</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Administer dose undiluted over 2 hours.</value>
<value>Administer dose undiluted over 1 hour.</value>
</instruction><volume><value>50 mL</value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>Head & Neck Cancer. Loading dose: Cycle 1.</value>
<value>Head & Neck Cancer. Maintenance dose.</value>
<value>Head & Neck Cancer. Reduced Maintenance dose due to drug effects.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3354</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose></maximumprndose><din><value>02271249</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>